Journal: Cancer Immunology, Immunotherapy : CII
Article Title: Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer
doi: 10.1007/s00262-025-04189-8
Figure Lengend Snippet: Cytokine array analysis of immune-related protein expression in Stk11 -KO mouse breast cancer cell lines and their parental counterparts. A Array map. B - D Representative cytokine array blots for PY8119 B , M158 C , and NF639 D cell lines, comparing Stk11 -KO cells with their parental counterparts. E Semiquantitative analysis of protein expression with a top tenfold change. Signal intensities were measured and expressed as fold changes relative to parental cells, based on the dot intensity from the cytokine array. The Wilcoxon rank-sum test compared the difference between Stk11 -KO and parental cells. Abbreviations: CTACK/CCL27, cutaneous T cell-attracting chemokine/C–C motif chemokine ligand 27; CXCL1/KC, chemokine (C-X-C motif) ligand 1; CXCL16, chemokine (C-X-C motif) ligand 16; IL-4, interleukin-4; M-CSF, macrophage colony-stimulating factor; MCP-2/CCL2, monocyte chemoattractant protein-1/C–C motif chemokine ligand 2; MCP-5, monocyte chemoattractant protein-5; MIP-2, macrophage inflammatory protein-2; and VEGF-A, vascular endothelial growth factor-A
Article Snippet: The M158, NF639, and PY8119 mouse cancer cells were obtained from ATCC®.
Techniques: Expressing